Marie-Louise Lunn is Global Product Manager at Novo Nordisk Pharmatech with on enzymes for bioprocessing. She holds a Ph.D. in molecular biology and drug discovery from the University of Copenhagen, Denmark. After working as a postdoctoral researcher at the Salk Institute for Biological Studies in San Diego, USA, she joined Exiqon Sales and Marketing in 2006, then worked for QIAGEN following the acquisition of Exiqon in 2017 and has been with Novo Nordisk Pharmatech since early 2024.